Cite
HARVARD Citation
Cantini, F. et al. (2020). Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study. Journal of infection. 81 (4), pp. 647-679. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cantini, F. et al. (2020). Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study. Journal of infection. 81 (4), pp. 647-679. [Online].